Stocktoria

AVITA Medical, Inc. RCEL

Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2012-03-18
Chart by TradingView
3/9
Piotroski F — financial health
-32.08
Altman Z″ — distress risk · distress
Dividend payout · no dividend

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Financials
Revenue$71.6M$64.3M$50.1M$34.4M$29.2M
Gross profit$58.8M$55.2M$42.4M$28.4M$23.3M
Operating income-$42.5M-$56.6M-$42.7M-$27.5M-$26.5M
Net income-$48.6M-$61.8M-$35.4M-$26.7M-$26.6M
Operating cash flow-$31.2M-$48.9M-$38.0M-$19.1M-$25.9M
Free cash flow-$32.2M-$58.1M-$39.4M-$19.5M-$26.8M
Total assets$56.4M$79.7M$111.6M$98.3M$125.5M
Total liabilities$73.0M$75.0M$61.9M$13.0M$9.8M
Shareholders' equity-$16.6M$4.5M$49.1M$84.7M$115.7M
Ratios
Gross margin82.1%85.8%84.5%82.4%79.6%
Operating margin-59.4%-88.1%-85.1%-79.9%-90.8%
Net margin-67.8%-96.3%-70.6%-77.5%-90.9%
FCF margin-45.0%-90.4%-78.6%-56.8%-91.7%
Return on assets-86.2%-77.6%-31.7%-27.1%-21.2%
Return on equity291.8%-1374.6%-72.1%-31.5%-23.0%
Debt / equity-0.00×9.39×0.81×
Current ratio0.572.837.888.1816.42
Revenue growth11.5%28.1%45.7%17.8%104.9%

Why these scores methodology →

Piotroski F-score: 3/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: -32.08 (distress)

  • Working capital / assets -0.482
  • Retained earnings / assets -7.242
  • EBIT / assets -0.754
  • Equity / liabilities -0.228

Sector peers

VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →

Source: SEC EDGAR filings · CIK 0001762303 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.